Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women

Use of systemic glucocorticoids and risk of breast cancer in a prospective cohort of postmenopausal women

Abstract Background Glucocorticoids could theoretically decrease breast cancer risk through their anti-inflammatory effects or increase risk through immunosuppression. However, epidemiological evidence is limited regarding the associations between glucocorticoid use and breast cancer risk. Methods W...

Full description

Bibliographic Details
Main Authors: Manon Cairat, Marie Al Rahmoun, Marc J. Gunter, Pierre-Etienne Heudel, Gianluca Severi, Laure Dossus, Agnès Fournier
Format: Article
Language:English
Published: BMC 2021-08-01
Series:BMC Medicine
Subjects:
Glucocorticoids
Breast cancer
Molecular status
Cancer stage
Oestrogen receptors
Postmenopausal women
Online Access:https://doi.org/10.1186/s12916-021-02004-6

Similar Items

Similar Items